SCHEMBL28570416

SCHEMBL28570416

COc1ccc(CC(OC(N)=O)C(N)=NO)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ LDHA P00338 1/20 0.50
▸ PPARG P37231 1/20 0.47
▸ PPARA Q07869 1/20 0.47
▸ CTBP2 P56545 1/20 0.46
▸ SLC6A4 P31645 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ CYP2C19 P33261 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.40
▸ PARP2 Q9UGN5 1/20 0.40
▸ PARP4 Q9UKK3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28570415 1.00 SMN1; SMN2 (0.50) SMN1; SMN2MAPK1LDHAPPARGPPARA
SCHEMBL28549393 0.85 LDHA (0.56) LDHAPPARGPPARASLC6A4POLB
SCHEMBL28557798 0.80 ALDH1A1 (0.45) SMN1; SMN2MAPK1LDHAPPARGPPARA
SCHEMBL28558905 0.79 LDHA (0.49) LDHAPPARGPPARASLC6A4POLB
SCHEMBL28558904 0.79 LDHA (0.49) LDHAPPARGPPARASLC6A4POLB
SCHEMBL28558423 0.78 LDHA (0.48) SMN1; SMN2LDHAPPARGPPARASLC6A4
SCHEMBL28558424 0.78 LDHA (0.48) SMN1; SMN2LDHAPPARGPPARASLC6A4
SCHEMBL7267958 0.76 LDHA (0.46) LDHAPPARGPPARASLC6A4POLB
SCHEMBL7267954 0.76 LDHA (0.46) LDHAPPARGPPARASLC6A4POLB
SCHEMBL4405215 0.75 LDHA (0.59) LDHAPPARGPPARASLC6A4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107848962-B Urea derivative or pharmacologically acceptable salt thereof 杏林制药株式会社 2021-04-09 — — CN disclosed
Send feedback